Changes in amitriptyline distribution in rat brain during a 14-day continuous infusion

Area of Science:

• Pharmacology
• Neuroscience
• Drug Metabolism

Background:

• Amitriptyline (ATL) is a widely used antidepressant.
• Understanding its distribution in the brain is crucial for therapeutic efficacy and safety.
• Pharmacokinetic studies are essential to elucidate drug behavior in vivo.

Purpose of the Study:

• To examine the distribution of amitriptyline (ATL) in 12 distinct rat brain regions.
• To investigate the temporal changes in ATL concentration and its metabolite, nortriptyline, over 2, 7, and 14 days of continuous infusion.
• To compare brain and serum concentrations of ATL and its metabolite.

Main Methods:

• Continuous infusion of amitriptyline (ATL) at 18 mg/kg/day in rats.
• Analysis of ATL and nortriptyline concentrations in 12 brain regions and serum at 2, 7, and 14 days.
• Calculation of brain/serum concentration ratios.

Main Results:

• Nortriptyline concentrations in brain and serum were significantly lower than ATL.
• The brain/serum concentration ratio and absolute brain ATL concentration were lower on day 2 compared to days 7 and 14.
• ATL serum levels were higher on day 2 than on subsequent days.
• ATL brain distribution was heterogeneous and changed over time in specific regions like the anterior basal ganglia and medulla oblongata + pons.

Conclusions:

• Amitriptyline exhibits time-dependent and region-specific distribution in the rat brain.
• Early-phase (day 2) pharmacokinetics show lower brain penetration and higher serum levels compared to later stages.
• These findings highlight the dynamic nature of ATL distribution and metabolism in the brain.